ReviewBiomarker research2022

HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives.

Weiling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.